Navigation Links
format in Medical Technology

Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format

Report Includes an Individual's Genetic Risk Based on Clinical Data, Preventive Measure Guidance and Scientific Educational Materials WALTHAM, Mass., July 22 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI ), today announced the launch of an enhanced test report format an...

HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens

...armaceutical compliance Mayberry points out. "In the United States today, the only class of drugs currently dispensed by manufacturers in a unit dose format with compliance-prompting features is birth control pills, and the most recent data shows that compliance rates with these drugs exceeds 92 percent. ...

HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject for Second Phase II Study

...roduct will result in helping millions of patients worldwide who suffer from these ulcers," said Travis E. Baugh, President of HEALTHPOINT. "The novel format of this cell-based therapy shows great potential to deliver a compelling, cost-effective option." The current trial is part of HEALTHPOINT's ongo...

Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences

...st will be available on Pharmasset's website for thirty days following the conference. The investor presentation will be available for download in PDF format immediately following the presentation in the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investo...

Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting

...s. However, SCORPION therapeutics are multispecific therapeutics that are capable of targeting two or more antigens simultaneously. Trubion's SCORPION format provides the basis for development of single therapies that simultaneously inhibit multiple ligand/receptor interactions or that manipulate cellular s...

Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers

...novative and effective treatment strategies for such high-risk wounds could provide tremendous benefits to both patients and society. "The novel format of this cell-based therapy shows great potential to deliver a compelling clinical and cost effectiveness profile," said Travis E. Baugh, President and...

Pieris Reports Development Progress for Anticalin(R) PRS-050, a Next Generation VEGF Antagonist

...nce their favorable tissue penetration with adjustable serum half-life. Moreover, Anticalins have been developed as Duocalins(R), whose dual targeting format allows multiple targets to be bound and modulated through a single molecule. Pieris exclusively owns the Anticalin patent estate, which offers complet...

Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass

...roved outcomes," said Karen Orloff Kaplan, Sc.D., Chief Executive Officer of the Ovarian Cancer National Alliance. About HE4 HE4 in a manual format is currently FDA cleared for monitoring recurrent or progressive disease in patients with EOC, and CE-marked in Europe as an aid in estimating the ris...

Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress

...al nervous system adverse events. The multi-center, double-blind, randomized Phase II study used a parallel-group, active-control format to evaluate the efficacy and safety of EXPAREL for prolonged postoperative analgesia. Either a single intraoperative administration of EXPAREL or act...

FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder

...ppropriate and safe use of PROMACTA, while minimizing risks. PROMACTA CARES is part of an ongoing collaboration between GSK and the FDA to provide a format for appropriate additional data collection. Additionally, PROMACTA CARES has an optional component: reimbursement support for the uninsured...

Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series

...um(TM) provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features over 400 rapid-f...

Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test

...evelop important diagnostics," said Peter Dansky, president of Applied Biosystems' functional analysis division. "The TaqMan Arrays provide an ideal format for surveying gene expression markers based in their easy-to-use format, high sensitivity, and ability to facilitate standardization among laboratorie...

Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics

... of the material previously needed and has 100-fold the throughput! The ability to analyze cell (and therefore mitochondrial) respiration in a 96 well format and at the same time measure glycolytic flux will result in an immediate surge of scientific discoveries and new drugs. In particular it can lead to a...

Palatin Technologies Presents PL-3994 Clinical Trial Results at the 12th Annual Scientific Meeting of the Heart Failure Association of America

...in plasma cGMP, and increases in urine volume and sodium excretion. There were no serious or severe adverse events. The data set presented in poster format is available for viewing on Palatin's website at http://www.palatin.com . Palatin completed a positive Phase 2a clinical study with PL-3994 last mo...

Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th

...st will be available on Pharmasset's website for thirty days following the conference. The investor presentation will be available for download in PDF format immediately following the presentation in the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.phar...

Joint Commission Urges Patients to 'Speak Up' About Pain

...venting errors in care. Brochures can be found at http://www.jointcommission.org . All of the Speak Up(TM) brochures are available in an easy-to-read format and in Spanish. Founded in 1951, The Joint Commission seeks to continuously improve the safety and quality of care provided to the public through th...

Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents

...clitaxel-eluting, sirolimus-eluting, or bare stents for the treatment of de novo coronary lesions). The PAINT study was designed with a unique 3-arm format that allows the evaluation of three stents that only differ on the presence and/or type of drug (all stents have exactly the same material, strut thic...

Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product

...s nicotine more than five times more effectively than the SNUS tobacco format, which is considered to represent the most efficacious smokeless tobacco format for nicotine delivery currently available. The study design was based upon the Lunell study of Swedish SNUS nicotine absorption. The Lunell study is...

Apieron, Inc. Begins Customer Shipments of the Insight(TM) eNO System

...convenient for the patient, and the disposable sensor generates a reading in less than a minute. Patient data can be stored and maintained in a unique format for trend analysis and printed for insurers' and patients' files. All of the System's functions are accessible through a small desktop monitor with a ...

Colorado Cancer Research Program Will Host Golf Event to 'Drive' the Message that Clinical Trials Play a Vital Role in the Quest to Find a Cure for Cancer

... include green fees, cart fees, a boxed lunch and dinner. Registration for this year's event begins at 11:30 am. This event has a best ball scramble format and will kick off with a shotgun start at 1:00 pm. In addition to first, second and third place prizes, there will be prizes for the best all-female t...

Synbiotics Corporation Announces Human Submission for FluDetect(R)

...pid point of care test for avian influenza in the veterinary field. FluDetect(R) has been heralded for its extreme sensitivity in a simple to use test format that requires no equipment, nor extensive training to perform. Management believes this may be the first crossover test to be licensed for use both in...

Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile

...he conference website at http://www.easl.ch/hepatitis-conference/program/session1.asp . The poster presentation will be available for download in PDF format after it is presented on February 14, 2008 in the "Events & Presentations" section of Pharmasset's website at http://investor.pharmasset.com/events.c...

Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART

.... The full conference abstracts are currently available for download in PDF format in the "Events & Presentations" section of Pharmasset's website at http://... . The full scientific presentations will be available for download in PDF format following the conference in the "Product Pipeline" section of Pharmasset's ...

Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium

...posium provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The five-day event features rapid-fire pre...

Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA

...l Prescribing Information (PI), including boxed WARNINGS, for APTIVUS at http://www.APTIVUS.com . The PI is in the new Physicians Labeling Rule (PLR) format required by the U.S. FDA. Additional Information about APTIVUS APTIVUS, a non-peptidic protease inhibitor, works by inhibiting protease, an enzyme n...

CLIA Waiver Submitted for Rapid HIV Test Employs StatSure's 'Barrel' Technology

...oard: SSUR - News) is pleased to announce that its patented, "barrel- test" format for the detection of antibodies to HIV-1/2 in human whole blood, serum, and...product and allow SDS to go forward with its plan to expand the use of this format to other infectious diseases and to establish new strategic partnerships." ...

AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy

...did not accumulate substantially in other tissues. Results of a previous clinical study performed by AOP Orphan in Europe presented in oral and poster format at the 20th Annual North American Cystic Fibrosis Conference, Denver, Colorado, November 2-5, 2006, indicated that dosing of Moli1901 for 5 consecutiv...

State of Diabetes in Pittsburgh: Pittsburgh Business Group on Health Releases Report

...able health care delivery system. The report was produced with assistance from sanofi-aventis U.S. LLC. The complete report is available in electronic format on PBGH's website at http://www.pbghpa.com and may be downloaded free of charge. About Pittsburgh...

Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA

... 1 clinical trial for the treatment of patients with non-Hodgkins lymphoma. The BiTE product development platform is based on a unique, antibody-based format that leverages the cytotoxic potential of T cells, the most powerful 'killer cells' of the human immune system. Adecatumumab (MT201), a recombinant hu...

MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule

... 1 clinical trial for the treatment of patients with non-Hodgkins lymphoma. The BiTE product development platform is based on a unique, antibody-based format that leverages the cytotoxic potential of T cells, the most powerful 'killer cells' of the human immune system. Adecatumumab (MT201), a recombinant hu...

Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune

... 1 clinical trial for the treatment of patients with non-Hodgkins lymphoma. The BiTE product development platform is based on a unique, antibody-based format that leverages the cytotoxic potential of T cells, the most powerful 'killer cells' of the human immune system. Adecatumumab (MT201), a recombinant hu...

EpiCept Corporation to Present New NP-1 Data at American Pain Society Meeting

...a product candidate intended for use in the management of pain resulting from various peripheral neuropathies. Two studies will be presented in poster format by Dennis Everton, RPh., Director of Clinical Development. Results from a new human pharmacokinetic study of NP-1 designed to assess the pharmacokin...

FDA approves MyocondaR IND for MAP in Crohn's Disease

...on of MyocondaR. This has resulted in a new product based on the original research. The Phase II/III trial is necessary due to the changes in the drug format which will now be an all-in-one oral capsule, the increased dosages and the new indication being sought. "We are very pleased to have reached this ...

Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors

...7. This clinical trial will evaluate XL999 in patients with NSCLC who have failed at least one previous therapy. The trial will have a dose-escalation format starting at 0.4 mg/kg dosed weekly, while monitoring patients for potential cardiovascular events. Results from this Phase I clinical trial could prov...

Santaris Pharma Presents Positive Clinical Data on SPC2996 in Chronic Lymphocytic Leukaemia

...antaris.com Detailed results of the Phase I/II Study A PDF of the results presented at the American Society of Clinical Oncology (ASCO) in poster format can be viewed and/or downloaded from the News section of the Company's website, www.santaris.com ....

First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy

...rt by grants from the National Institutes of Health and the Food Allergy and Anaphylaxis Network. A copy of the study is available to reporters in PDF format by email request from the American Association of Immunologists at infoji@aai.org. About Luna Innovations Incorporated: Luna Innovations Incorpora...

Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology

... the encumbering patent landscape as currently present for the development of conventional antibodies. About the Duocalin(R) technology Pieris can format Anticalin leads as dual targeting proteins, so-called Duocalins. A Duocalin binds two separate therapeutic targets in one easily produced protein usin...

MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions

...June 21, 2007 /PRNewswire/ -- What and When Data from the PROactive and CHICAGO studies of ACTOS(R) (pioglitazone HCl) will be presented in poster format at the 67th Scientific Sessions of the American Diabetes Association in Chicago: -- Hospitalizations for serious adverse events in high-risk ty...

Publication Confirms that EpCAM, the Target for Two of Micromet's Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers

...1 clinical trial for the treatment of patients with non-Hodgkin's lymphoma. The BiTE product development platform is based on a unique, antibody-based format that leverages the cytotoxic potential of T cells, widely recognized as the most powerful 'killer cells' of the human immune system. Adecatumumab (MT2...

Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference

...1 clinical trial for the treatment of patients with non-Hodgkin's lymphoma. The BiTE product development platform is based on a unique, antibody-based format that leverages the cytotoxic potential of T cells, widely recognized as the most powerful 'killer cells' of the human immune system. Adecatumumab (MT2...
Other Tags
(Date:9/18/2014)... system that can operate inside the bore of an ... a biomedical research partnership program at Brigham and Women,s ... the robot, in conjunction with real-time MRI images, can ... and less discomforting for the patient. The novel system ... with greater precision. , Developed by a team of ...
(Date:9/18/2014)... No matter how many times it,s demonstrated, ... communicating creatures. , But by using a ... radically alter their behavior to suit their population. ... them are present, and act accordingly. , Once ... it may change from innocuous to pathogenic, or ...
(Date:9/18/2014)... stored in DNA, tiny strands of nucleic acid that ... express this genetic data, our DNA is copied into ... that perform tasks in our cells. , Several ... molecule. Unlike all other known RNAs, this molecule is ... are abundant, little has been known about how they ...
Breaking Biology News(10 mins):Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 2Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 3Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 4Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 5Researchers study vital 'on/off switches' that control when bacteria turn deadly 2Researchers study vital 'on/off switches' that control when bacteria turn deadly 3Scientists find how mysterious 'circular RNA' is formed, claim muscular dystrophy link 2
(Date:9/19/2014)... 19, 2014 (HealthDay News) -- The U.S. Food and Drug ... Thursday. Trulicity is part of a class of once-a-week injectable ... type 2 diabetes. "Trulicity is a new treatment ... treatment regimens to control blood sugar levels in the overall ... of the FDA,s Office of Drug Evaluation II, said in ...
(Date:9/19/2014)... cells to treat and cure disease is a ... hindered by the inability of doctors and scientists to ... cells in patients without resorting to invasive procedures, like ... in the online journal Magnetic Resonance in Medicine ... School of Medicine, University of Pittsburgh and elsewhere describe ...
(Date:9/19/2014)... Recent two-generation approaches to reducing poverty that help ... from researchers, advocates, and foundations. By combining education ... move to jobs that offer a path out ... for children, these programs aim to improve the ... a new report from the National Center for ...
(Date:9/19/2014)... Sept. 19, 2014 (HealthDay News) -- More states are ... medication epinephrine to use for any child having a ... treatment for "anaphylaxis," an allergic reaction that can lead ... blood pressure and even death. In people ... or tree nuts, insect venom or certain drugs, anaphylaxis ...
(Date:9/19/2014)... 19, 2014 Top 10 Best ... announced that HostGator.com, GoDaddy and Bluehost are among ... companies are the most recommended suppliers for webmasters ... to buy high quality Linux hosting (including VPS ... is one of many top hosting companies that ...
Breaking Medicine News(10 mins):Health News:FDA Approves Another Weekly Injectable Drug for Type 2 Diabetes 2Health News:A better way to track emerging cell therapies using MRIs 2Health News:A two generation lens: Current state policies fail to support families with young children 2Health News:More Schools Stocking Shots That Counter Serious Allergic Reactions 2Health News:More Schools Stocking Shots That Counter Serious Allergic Reactions 3Health News:Top10BestSEOHosting.com Announces Great Linux Web Hosting Suppliers In 2014 2
Other Contents